Document Detail

Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting.
MedLine Citation:
PMID:  19043379     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Because systemic treatment of psoriasis is associated with several adverse effects, methotrexate (MTX), either topically or as targeted delivery, has become a more-interesting alternative. MATERIAL/METHODS: Methotrexate liposomes (LMTX) were prepared from DPPC, soy PC, egg yolk PC, and cholesterol. We studied the characterization, formulation of hydrogel (MTX 0.25%), and skin permeability, and compared LMTX gel with plain MTX gel and placebo for treating localized psoriasis in a double-blind study using albino mice. Gel formulations were applied daily, followed by irradiation with 80 joules from a 650-nm diode laser 3 times weekly for 12 weeks. Changes in disease signs and histopathological features were assessed. RESULTS: Drug release increased as laser energy increased following Higuchi's diffusion model and changed to zero order with energies > or = 80 J; significantly more MTX was released at all time intervals. Both LMTX and FMTX gels showed zero order kinetic release and antipsoriatic activity. During 8 months' follow-up, up to 60% of the patients treated with LMTX gel had no recurrence; this difference was statistically significant. No clinically significant changes were seen regarding blood or other laboratory variables. CONCLUSIONS: Application of an 80-J diode laser to 0.25% LMTX hydrogel was beneficial for relieving psoriasis and did not exert systemic toxicity.
Maha Fadel Mohamed Ali; Manal Salah; Maha Rafea; Nadia Saleh
Related Documents :
17153649 - Measuring early plaque formation clinically.
17296769 - Sucrose concentration alters fermentation kinetics, products, and carbon fates during i...
8480989 - Mycelial elongation and sporulation of two fungi on amended media in light or dark.
23865119 - Positive movement experiences: approaching the study of athletic participation, exercis...
15328699 - Antibacterial properties of chitosan in waterborne pathogen.
14627299 - Microbial and sensory quality of marinated and irradiated chicken.
20438009 - A multicomponent exercise program for institutionalized older adults.
19425819 - Effect of acute and chronic whole-body vibration exercise on serum insulin-like growth ...
9761089 - Predictors of sudden cardiac death in hypertrophic cardiomyopathy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Medical science monitor : international medical journal of experimental and clinical research     Volume:  14     ISSN:  1643-3750     ISO Abbreviation:  Med. Sci. Monit.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-01     Completed Date:  2009-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9609063     Medline TA:  Med Sci Monit     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  PI66-74     Citation Subset:  IM    
Department of Medical Laser Applications, National Institute of Laser Enhanced Sciences, Cairo University, Pharmaceutical Technology Unit, Cairo, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Topical
Double-Blind Method
Immunosuppressive Agents / administration & dosage*,  pharmacokinetics,  therapeutic use
Methotrexate / administration & dosage*,  pharmacokinetics,  therapeutic use
Middle Aged
Psoriasis / drug therapy*
Reg. No./Substance:
0/Hydrogels; 0/Immunosuppressive Agents; 0/Liposomes; 0/Placebos; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Postoperative analgosedation with S(+)-ketamine decreases the incidences of postanesthetic shivering...
Next Document:  The retinoblastoma paradigm revisited.